BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36595529)

  • 21. Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2.
    Nishi K; Yoshimoto S; Nishi S; Tsunoda T; Ohno J; Yoshimura M; Hiromatsu K; Yamano T
    In Vivo; 2022; 36(1):371-374. PubMed ID: 34972736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
    Vilella F; Wang W; Moreno I; Roson B; Quake SR; Simon C
    Hum Reprod; 2021 Sep; 36(10):2709-2719. PubMed ID: 34329437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
    J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues.
    Stanley KE; Thomas E; Leaver M; Wells D
    Fertil Steril; 2020 Jul; 114(1):33-43. PubMed ID: 32622411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression Pattern of the SARS-CoV-2 Entry Genes
    Liu Y; Qu HQ; Qu J; Tian L; Hakonarson H
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33081421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
    Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Mdkhana B; Al Heialy S; Ratemi E; Alghamdi M; Abusnana S; Kashour T; Hamid Q; Halwani R
    Arch Toxicol; 2020 Dec; 94(12):4037-4041. PubMed ID: 32808185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation.
    Xiao Y; Yan Y; Chang L; Ji H; Sun H; Song S; Feng K; Nuermaimaiti A; Lu Z; Wang L
    Antiviral Res; 2023 Apr; 212():105558. PubMed ID: 36806814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells.
    Yang H; Yuan H; Zhao X; Xun M; Guo S; Wang N; Liu B; Wang H
    Virol Sin; 2022 Jun; 37(3):380-389. PubMed ID: 35272059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.
    Saiz ML; DeDiego ML; López-García D; Corte-Iglesias V; Baragaño Raneros A; Astola I; Asensi V; López-Larrea C; Suarez-Alvarez B
    Clin Epigenetics; 2021 Oct; 13(1):187. PubMed ID: 34635175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise-induced myokines downregulates the ACE2 level in bronchial epithelial cells: Implications for SARS-CoV-2 prevention.
    Bhardwaj V; Dela Cruz M; Subramanyam D; Kumar R; Markan S; Parker B; Roy HK
    PLoS One; 2022; 17(7):e0271303. PubMed ID: 35857747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.
    Shukla SP; Cho KB; Rustagi V; Gao X; Fu X; Zhang SX; Guo B; Udugamasooriya DG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous susceptibility to SARS-CoV-2 infection according to the expression of viral entry factors in the skin.
    Garduño-Soto M; Choreño-Parra JA
    Gac Med Mex; 2020; 156(4):354-357. PubMed ID: 32831324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Roshan R; Azam F; Mehta J; Handu S; Prasad R; Jain N; Pandey AK; Dhamija P
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML
    Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
    Menon R; Otto EA; Sealfon R; Nair V; Wong AK; Theesfeld CL; Chen X; Wang Y; Boppana AS; Luo J; Yang Y; Kasson PM; Schaub JA; Berthier CC; Eddy S; Lienczewski CC; Godfrey B; Dagenais SL; Sohaney R; Hartman J; Fermin D; Subramanian L; Looker HC; Harder JL; Mariani LH; Hodgin JB; Sexton JZ; Wobus CE; Naik AS; Nelson RG; Troyanskaya OG; Kretzler M
    Kidney Int; 2020 Dec; 98(6):1502-1518. PubMed ID: 33038424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.